QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

Caribou Biosciences (CRBU) SEC Filings & 10K Form

$6.84
+0.03 (+0.44%)
(As of 02/21/2024 ET)

Recent Caribou Biosciences SEC Filings

DateFilerForm TypeView
02/14/2024
5:30 AM
Caribou Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/08/2024
4:06 PM
Caribou Biosciences (Issuer)
Kanner Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
3:59 PM
BlackRock Inc. (Filed by)
Caribou Biosciences (Subject)
Form SC 13G/A
01/25/2024
6:20 AM
Caribou Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:18 PM
Caribou Biosciences (Issuer)
Kelly Timothy P (Reporting)
Form 3/A
01/09/2024
3:10 PM
Caribou Biosciences (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:18 PM
Avidity Partners Management LP (Filed by)
Caribou Biosciences (Subject)
Form SC 13G
01/08/2024
7:00 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:05 PM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
7:02 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
3:15 PM
Caribou Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
07/14/2023
4:31 PM
Caribou Biosciences (Filer)
Form 424B5
07/14/2023
3:22 PM
Caribou Biosciences (Filer)
Form 8-K/A
07/13/2023
3:23 PM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
3:17 PM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
8:10 AM
Caribou Biosciences (Subject)
PFIZER INC (Filed by)
Form SC 13G
07/06/2023
7:01 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2023
3:31 PM
Caribou Biosciences (Issuer)
Haurwitz Rachel E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:00 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2023
7:00 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2023
7:00 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2023
3:16 PM
Caribou Biosciences (Issuer)
Haurwitz Rachel E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2023
4:18 PM
Caribou Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2023
4:30 PM
Caribou Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/23/2023
4:09 PM
Caribou Biosciences (Issuer)
Zheng Ran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:09 PM
Caribou Biosciences (Issuer)
Rizvi Syed Ali-aamir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:10 PM
Caribou Biosciences (Issuer)
MCCLUNG BARBARA G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:10 PM
Caribou Biosciences (Issuer)
GUGGENHIME ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:11 PM
Braunstein Scott (Reporting)
Caribou Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:12 PM
Caribou Biosciences (Issuer)
Sacks Natalie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:12 PM
Caribou Biosciences (Issuer)
Khan Ruhi Ahmad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:12 PM
Caribou Biosciences (Issuer)
Richardson-Heron Dara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:13 PM
Caribou Biosciences (Issuer)
Kanner Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
4:14 PM
Caribou Biosciences (Issuer)
Haurwitz Rachel E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
3:46 PM
Caribou Biosciences (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
3:47 PM
Caribou Biosciences (Issuer)
O'Byrne Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
3:48 PM
Caribou Biosciences (Issuer)
Whiting Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CRBU) was last updated on 2/21/2024 by MarketBeat.com Staff